Multicenter clinical performance evaluation of BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus

J. Jeremiah Bell; Evan J. Anderson; Wallace Greene; José R. Romero; Moheet Merchant; Rangaraj Selvarangan

doi:10.1016/j.jcv.2014.05.020

Multicenter clinical performance evaluation of BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus

J. Jeremiah Bell
, Evan J. Anderson
, Wallace Greene
, José R. Romero
, Moheet Merchant
, Rangaraj Selvarangan

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Background: BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a new-generation lateral flow immunochromatographic assay for objective detection of RSV in respiratory specimens from children. Objective: To evaluate the performance of BD Veritor™ System for Rapid Detection of RSV in respiratory specimens collected from pediatric patients. Study design: A prospective, multicenter clinical trial was undertaken at five study sites representing geographically diverse regions of the U.S. to assess the performance of the BD Veritor™ System for Rapid Detection of RSV in comparison to R-mix shell vial culture and ProFlu+ reverse transcription-PCR assay (Gen-Probe/Prodesse). Results: 440 nasopharyngeal washes/aspirates (NPW/A) and 706 nasopharyngeal swab (NPS) specimens from U.S. subjects. <. 20 years of age were collected and tested using the BD Veritor™ System and compared with shell vial culture and real-time RT-PCR results. Analysis of the data indicates the overall sensitivity and specificity for BD Veritor™ System for all sample types combined was 90% and 97.0% versus shell vial culture and 75.5% and 98.7% versus RT-PCR respectively. Conclusion: Overall, the BD Veritor™ System for the Rapid Detection of RSV performed well when compared to both viral cell culture and RT-PCR in children.

Original language	English (US)
Pages (from-to)	113-117
Number of pages	5
Journal	Journal of Clinical Virology
Volume	61
Issue number	1
DOIs	https://doi.org/10.1016/j.jcv.2014.05.020
State	Published - Sep 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Virology
Infectious Diseases

Access to Document

10.1016/j.jcv.2014.05.020

Cite this

@article{170eb07058314c808da12c0ac6b44849,

title = "Multicenter clinical performance evaluation of BD Veritor{\texttrademark} System for Rapid Detection of Respiratory Syncytial Virus",

abstract = "Background: BD Veritor{\texttrademark} System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a new-generation lateral flow immunochromatographic assay for objective detection of RSV in respiratory specimens from children. Objective: To evaluate the performance of BD Veritor{\texttrademark} System for Rapid Detection of RSV in respiratory specimens collected from pediatric patients. Study design: A prospective, multicenter clinical trial was undertaken at five study sites representing geographically diverse regions of the U.S. to assess the performance of the BD Veritor{\texttrademark} System for Rapid Detection of RSV in comparison to R-mix shell vial culture and ProFlu+ reverse transcription-PCR assay (Gen-Probe/Prodesse). Results: 440 nasopharyngeal washes/aspirates (NPW/A) and 706 nasopharyngeal swab (NPS) specimens from U.S. subjects. <. 20 years of age were collected and tested using the BD Veritor{\texttrademark} System and compared with shell vial culture and real-time RT-PCR results. Analysis of the data indicates the overall sensitivity and specificity for BD Veritor{\texttrademark} System for all sample types combined was 90\% and 97.0\% versus shell vial culture and 75.5\% and 98.7\% versus RT-PCR respectively. Conclusion: Overall, the BD Veritor{\texttrademark} System for the Rapid Detection of RSV performed well when compared to both viral cell culture and RT-PCR in children.",

author = "Bell, \{J. Jeremiah\} and Anderson, \{Evan J.\} and Wallace Greene and Romero, \{Jos{\'e} R.\} and Moheet Merchant and Rangaraj Selvarangan",

year = "2014",

month = sep,

doi = "10.1016/j.jcv.2014.05.020",

language = "English (US)",

volume = "61",

pages = "113--117",

journal = "Journal of Clinical Virology",

issn = "1386-6532",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Multicenter clinical performance evaluation of BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus

AU - Bell, J. Jeremiah

AU - Anderson, Evan J.

AU - Greene, Wallace

AU - Romero, José R.

AU - Merchant, Moheet

AU - Selvarangan, Rangaraj

PY - 2014/9

Y1 - 2014/9

N2 - Background: BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a new-generation lateral flow immunochromatographic assay for objective detection of RSV in respiratory specimens from children. Objective: To evaluate the performance of BD Veritor™ System for Rapid Detection of RSV in respiratory specimens collected from pediatric patients. Study design: A prospective, multicenter clinical trial was undertaken at five study sites representing geographically diverse regions of the U.S. to assess the performance of the BD Veritor™ System for Rapid Detection of RSV in comparison to R-mix shell vial culture and ProFlu+ reverse transcription-PCR assay (Gen-Probe/Prodesse). Results: 440 nasopharyngeal washes/aspirates (NPW/A) and 706 nasopharyngeal swab (NPS) specimens from U.S. subjects. <. 20 years of age were collected and tested using the BD Veritor™ System and compared with shell vial culture and real-time RT-PCR results. Analysis of the data indicates the overall sensitivity and specificity for BD Veritor™ System for all sample types combined was 90% and 97.0% versus shell vial culture and 75.5% and 98.7% versus RT-PCR respectively. Conclusion: Overall, the BD Veritor™ System for the Rapid Detection of RSV performed well when compared to both viral cell culture and RT-PCR in children.

AB - Background: BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV) is a new-generation lateral flow immunochromatographic assay for objective detection of RSV in respiratory specimens from children. Objective: To evaluate the performance of BD Veritor™ System for Rapid Detection of RSV in respiratory specimens collected from pediatric patients. Study design: A prospective, multicenter clinical trial was undertaken at five study sites representing geographically diverse regions of the U.S. to assess the performance of the BD Veritor™ System for Rapid Detection of RSV in comparison to R-mix shell vial culture and ProFlu+ reverse transcription-PCR assay (Gen-Probe/Prodesse). Results: 440 nasopharyngeal washes/aspirates (NPW/A) and 706 nasopharyngeal swab (NPS) specimens from U.S. subjects. <. 20 years of age were collected and tested using the BD Veritor™ System and compared with shell vial culture and real-time RT-PCR results. Analysis of the data indicates the overall sensitivity and specificity for BD Veritor™ System for all sample types combined was 90% and 97.0% versus shell vial culture and 75.5% and 98.7% versus RT-PCR respectively. Conclusion: Overall, the BD Veritor™ System for the Rapid Detection of RSV performed well when compared to both viral cell culture and RT-PCR in children.

UR - https://www.scopus.com/pages/publications/84905079612

UR - https://www.scopus.com/pages/publications/84905079612#tab=citedBy

U2 - 10.1016/j.jcv.2014.05.020

DO - 10.1016/j.jcv.2014.05.020

M3 - Article

C2 - 25034375

AN - SCOPUS:84905079612

SN - 1386-6532

VL - 61

SP - 113

EP - 117

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

IS - 1

ER -

Multicenter clinical performance evaluation of BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this